Suppr超能文献

静脉注射氨甲环酸对全肩关节置换术中失血及术后早期疼痛的影响。

The effect of intravenous tranexamic acid on blood loss and early post-operative pain in total shoulder arthroplasty.

作者信息

Pauzenberger L, Domej M A, Heuberer P R, Hexel M, Grieb A, Laky B, Blasl J, Anderl W

机构信息

St. Vincent Shoulder & Sports Clinic, Baumgasse 20A, 1030 Vienna, Austria.

St. Vincent Hospital Vienna, Austria, Stumpergasse 13, 1060 Vienna, Austria.

出版信息

Bone Joint J. 2017 Aug;99-B(8):1073-1079. doi: 10.1302/0301-620X.99B8.BJJ-2016-1205.R1.

Abstract

AIMS

The purpose of the present study was to evaluate the impact of intravenous tranexamic acid on the reduction of blood loss, transfusion rate, and early post-operative clinical outcome in total shoulder arthroplasty.

PATIENTS AND METHODS

A randomised, placebo-controlled trial which included 54 patients undergoing unilateral primary stemless anatomical or stemmed reverse total shoulder arthroplasty was undertaken. Patients received either 100 ml saline (placebo, n = 27), or 100 ml saline together with 1000 mg of tranexamic acid (TXA, n = 27) intravenously prior to skin incision and during wound closure. Peri-operative blood loss via an intra-articular drain was recorded and total blood loss was calculated. The post-operative transfusion rate was documented. Assessment of early clinical parameters included the visual analogue scale for pain (VAS), documentation of haematoma formation and adverse events.

RESULTS

Mean peri-operative blood drainage (placebo: 170 ml TXA: 50 ml, p = 0.001) and calculated mean total blood loss (placebo: 1248.2 ml TXA: 871.0 ml, p = 0.009) were significantly lower in the TXA group. No transfusions were necessary during the study period in either group. Mean VAS for pain significantly decreased from pre-operative (VAS 7) to the early post-operative period (VAS 1.7, p < 0.001). Significant differences regarding mean post-operative pain between placebo (VAS 2.0) and TXA (VAS 1.3) were detected (p = 0.05). The occurrence of haematomas was significantly more frequent in the placebo (59.3%, n = 16) than in the TXA group (25.9%, n = 6, p = 0.027). Whereas only mild haematomas developed in the TXA group, in the placebo group a total of 22.2% (n = 6) developed either moderate or severe haematomas. No adverse events associated with administration of TXA occurred.

CONCLUSION

Intravenous administration of TXA successfully reduced mean peri-operative blood drainage, total estimated blood loss, pain during the first post-operative days, and haematoma formation in total shoulder arthroplasty. Cite this article: 2017;99-B:1073-9.

摘要

目的

本研究旨在评估静脉注射氨甲环酸对全肩关节置换术中减少失血、输血率及术后早期临床结局的影响。

患者与方法

进行了一项随机、安慰剂对照试验,纳入54例行单侧初次无柄解剖型或有柄反向全肩关节置换术的患者。患者在皮肤切开前及伤口缝合期间,静脉注射100ml生理盐水(安慰剂组,n = 27)或100ml生理盐水加1000mg氨甲环酸(氨甲环酸组,n = 27)。记录关节内引流管的围手术期失血量并计算总失血量。记录术后输血率。早期临床参数评估包括疼痛视觉模拟评分(VAS)、血肿形成记录及不良事件。

结果

氨甲环酸组的平均围手术期引流量(安慰剂组:170ml;氨甲环酸组:50ml,p = 0.001)及计算得出的平均总失血量(安慰剂组:1248.2ml;氨甲环酸组:871.0ml,p = 0.009)显著更低。两组在研究期间均无需输血。疼痛的平均VAS评分从术前(VAS 7)显著降至术后早期(VAS 1.7,p < 0.001)。检测到安慰剂组(VAS 2.0)和氨甲环酸组(VAS 1.3)术后平均疼痛存在显著差异(p = 0.05)。安慰剂组血肿发生率(59.3%,n = 16)显著高于氨甲环酸组(25.9%,n = 6,p = 0.027)。氨甲环酸组仅出现轻度血肿,而安慰剂组共有22.2%(n = 6)出现中度或重度血肿。未发生与氨甲环酸给药相关的不良事件。

结论

静脉注射氨甲环酸成功减少了全肩关节置换术中的平均围手术期引流量、估计总失血量、术后首日疼痛及血肿形成。引用本文:2017;99 - B:1073 - 9。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验